High Gross Profit MarginKontigo's reported gross profit margin above 100% indicates its core products and services have very low direct costs relative to revenues. That structural margin supports scalable unit economics, funds product development and customer support, and provides a durable buffer against pricing pressure.

Low Financial LeverageA debt-to-equity ratio of 0.047 and a healthy equity ratio mean the company carries minimal financial leverage. Low debt reduces interest expense risk, preserves capital flexibility to fund operations or strategic initiatives, and enhances resilience across economic cycles.

Positive EBITDA & Operating Cash GenerationPositive EBITDA alongside operating cash flow that outpaces net income shows the core business generates cash before capex and financing. Sustained operational cash generation can support reinvestment into R&D and sales, improving long-term viability if free cash flow conversion is restored.

Bears Say

Steep Revenue DeclineA TTM revenue decline of -55.7% signals a severe loss of top-line momentum. Such a structural drop reduces scale economics, weakens pricing power and customer reach, and makes fixed-cost absorption harder, jeopardizing long-term margin recovery and investment capacity.

Free Cash Flow DeteriorationFree cash flow growth down -278.6% reflects a sharp deterioration in cash available after capital needs. Persistent negative FCF growth forces reliance on external financing or equity raises, limiting ability to fund R&D, scale sales, or buffer operational shocks over the medium term.

Negative Profitability And ReturnsNegative net profit and EBIT margins, together with a negative return on equity in the TTM period, indicate the company is not generating shareholder returns. Structural unprofitability constrains retained earnings, pressures cash reserves, and may necessitate cost cuts or dilution to fund growth.

KONT FAQ

What was Kontigo Care AB’s price range in the past 12 months?

Kontigo Care AB lowest stock price was kr1.59 and its highest was kr2.70 in the past 12 months.

What is Kontigo Care AB’s market cap?

Kontigo Care AB’s market cap is kr58.70M.

When is Kontigo Care AB’s upcoming earnings report date?

Kontigo Care AB’s upcoming earnings report date is May 15, 2026 which is in 87 days.

How were Kontigo Care AB’s earnings last quarter?

Kontigo Care AB released its earnings results on Jan 30, 2026. The company reported -kr0.035 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.035.

Is Kontigo Care AB overvalued?

According to Wall Street analysts Kontigo Care AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Kontigo Care AB pay dividends?

Kontigo Care AB does not currently pay dividends.

What is Kontigo Care AB’s EPS estimate?

Kontigo Care AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kontigo Care AB have?

Kontigo Care AB has 35,251,427 shares outstanding.

What happened to Kontigo Care AB’s price movement after its last earnings report?

Kontigo Care AB reported an EPS of -kr0.035 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2%.

Which hedge fund is a major shareholder of Kontigo Care AB?

Currently, no hedge funds are holding shares in SE:KONT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Kontigo Care AB

Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol dependence; and Previct Gambling, a digital tool for the treatment of gambling addiction. The company was incorporated in 2013 and is headquartered in Uppsala, Sweden.